Changes in MDA‐LDL level, LDL‐C level, and MDA‐LDL/LDL‐C ratio
MDA‐LDL levels, LDL‐C levels, and MDA‐LDL/LDL‐C ratios at baseline and 24 months in both treatment groups are depicted in Supporting Information: Table Association between time and estimated changes in the (A) MDA‐LDL level, (B) LDL‐C level, and (C) MDA‐LDL/LDL‐C ratio in the febuxostat and control groups. LDL‐C, low‐density lipoprotein cholesterol; MDA‐LDL, malondialdehyde‐modified low‐density lipoprotein.